Yale settles lawsuit over nurse replacing fentanyl with saline

A group of 95 women has reached a settlement with Yale University after a fertility clinic failed to provide pain relief during in vitro medical procedures, lawyers for the plaintiffs announced on Monday. 

In a lawsuit, the patients said Yale's Reproductive Endocrinology and Infertility Clinic performed extremely painful egg extractions, ignoring their pleas to ensure fentanyl was properly administered.

While clinicians at Yale did think they gave the patients fentanyl, a nurse working on staff had stolen the vials for her own use, diluting the drug with a saline solution, the plaintiffs claimed. 

A clinician at Yale finally noticed caps on the fentanyl vials were loose, indicative of tampering. After that, the situation was remedied. However, that took several months—the exact time length is disputed, but investigation concluded it was from June 2020 to Oct. 2020, at least. 

Investigators also said around 75% of the painkiller administered to patients was either entirely saline or diluted during that period.

Yale was accused of poorly controlling addictive substances and negligence. While specific payouts were not mentioned, attorneys for the women said Yale agreed to pay “substantial damages.”

In its own statement, Yale said it had made changes to curb any future incidents from occurring. 

"We will continue to do everything we can to ensure our patients and staff feel heard and that we have the strongest protections in place for them," read a statement from Yale. 

The nurse who stole the fentanyl for personal use was criminally prosecuted and later pleaded guilty. 

Chad Van Alstin Health Imaging Health Exec

Chad is an award-winning writer and editor with over 15 years of experience working in media. He has a decade-long professional background in healthcare, working as a writer and in public relations.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.